Immunosuppression Management, Outcomes And Challenges In Children With Liver And Kidney Transplant Recipients In The Covid-19 Pandemic Single Center Experience

Öz

Purpose: The COVID-19 pandemic has had a significant impact on solid organ transplantation (SOT), creating challenges in clinical management and contributing to substantial morbidity and mortality. By presenting our experience with immunosuppressive therapy management during COVID-19 infection in liver and kidney transplant recipients followed at our center, we want to raise awareness among transplant physicians about the effects of COVID-19 and discuss their management.

Methods: The files of patients who were followed up with a diagnosis of COVID-19 at the Istanbul Faculty of Medicine Pediatric Pandemic Service and outpatient clinic between January 2020 and January 2023 were retrospectively evaluated. Demographic characteristics, transplantation characteristics, immunosuppression treatments, COVID-19 severity, and laboratory parameters were evaluated.

Results: Thirty children diagnosed with COVID-19, with a history of liver and kidney transplantation, were included in the study. Twenty-one of these patients (n = 21, 70%) were liver transplant recipients and 9 (n = 9, 30%) were kidney transplant recipients. A total of 53.3% of the patients were male (n = 16) and the mean age was 10.1±4,85 years. Mild-to-moderate disease was observed in 93.3% patients. The rate of comorbidities, such as hypertension, obesity, and chronic lung disease, was 16.7%, and the hospitalization rate was significantly higher in these patients (p = 0.014). Of the nine patients whose immunosuppressive treatment was discontinued, three were kidney transplant recipients and six were liver transplant recipients; there was no statistically significant difference between them in terms of treatment discontinuation (p = 1,000). Patients in whom immunosuppressive treatment was discontinued had a significantly higher rate of severe disease (p = 0.049). Myocarditis was detected in one kidney transplant patient. No mortality was observed in any patient. The COVID-19 vaccination rate among patients was 13% (n = 4/30).

Conclusions: Pediatric liver and kidney transplant recipients generally experienced mild COVID-19 courses without mortality. Comorbidities were associated with hospitalization. Severe disease was linked to immunosuppressive discontinuation, particularly mycophenolate mofetil. Our findings highlight the importance of individualized immunosuppression management during COVID-19 in pediatric transplant recipients.

Anahtar Kelimeler

• COVID-19
• transplantation
• liver
• kidney
• immunosuppressive therapy

Kaynakça

1. Organization WH. World Health Organization Coronavirus (COVID-19) Dashboard August, 2025, https://covid19.who.int/. (2025). google scholar
2. Gagliotti C, Morsillo F, Moro ML, et al. Infections in liver and lung transplant recipients: a national prospective cohort Eur J Clin Microbiol Infect Dis 2018; 37: 399-407. 20180129. DOI: 10.1007/s10096-018-3183-0. google scholar
3. Kulkarni AV, Tevethia HV, Premkumar M et al. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021; 38: 101025. 20210713. DOI: 10.1016/j.eclinm.2021.101025. google scholar
4. Organization WH. Clinical management of COVID-19: Living guideline, 18 August 2023, https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.2 (2023, accessed 18 August 2023 2023). google scholar
5. Boyarsky BJ, Werbel WA, Durand CM, et al. Early national and center-level changes in kidney transplantation in the United States during the COVID-19 epidemic Am J Transplant 2020; 20: 3131-3139. 20200805. DOI: 10.1111/ajt.16167. google scholar
6. Khazaaleh S, Suarez ZK, Alomari M et al. Liver transplantation in the middle of the COVID-19 era: Our center’s experience World J Clin Cases 2023; 11: 316-321. DOI: 10.12998/ wjcc.v11.i2.316. google scholar
7. Charnaya O, Chiang TP, Wang R et al. Effects of the COVID-19 pandemic on pediatric kidney transplantation in the United States Pediatr Nephrol 2021; 36: 143-151. 20200926. DOI: 10.1007/s00467-020-04764-4. google scholar
8. Kemme S, Yoeli D, Sundaram SS, et al. Decreased access to pediatric liver transplantation during the COVID-19 pandemic Pediatr Transplant 2022; 26: e14162. 20211011. DOI: 10.1111/ petr.14162. google scholar

9. Strauss AT, Boyarsky BJ, Garonzik-Wang JM, et al. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses Am J Transplant 2021; 21: 1838-1847. 20201110. DOI: 10.1111/ajt.16373. google scholar
10. Lobritto S, Danziger-Isakov L, Michaels MG, et al. Impact of the COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs Front Pediatr 2020; 8: 612627. 20201210. DOI: 10.3389/fped.2020.612627. google scholar
11. Kehar M, Ebel NH, Ng VL, et al. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children with Liver Transplant and Native Liver Disease: An International Observational Registry Study J Pediatr Gastroenterol Nutr 2021; 72: 807-814. DOI: 10.1097/ MPG.0000000000003077. google scholar
12. Kehar M, Ebel N, Ng V et al. Updates from the NASPGHAN/SPLIT SARS-CoV2 International Registry. J Pediatr Gastroenterol Nutr 2022;74: e43-e44. DOI: 10.1097/ MPG.0000000000003326. google scholar
13. Ravanan R, Callaghan CJ, Mumford L et al. SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study. Am J Transplant 2020; 20: 3008-3018. 20200916. DOI: 10.1111/ajt.16247. google scholar
14. Goss MB, Galvan NTN, Ruan W et al. The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series Pediatr Transplant 2021; 25: e13868. 20201109. DOI: 10.1111/petr.13868. google scholar
15. Talgam-Horshi E, Mozer-Glassberg Y, Waisbourd-Zinman O et al. Clinical Outcomes and Antibody Response in COVID-19-Positive Pediatric Solid Organ Transplant Recipients Pediatr Infect Dis J 2021; 40: e514-e516. DOI: 10.1097/INF.0000000000003293. google scholar
16. Canpolat N, Yildirim ZY, Yildiz N et al. COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. Eur J Pediatr 2022; 181: 117-123. 20210703. DOI: 10.1007/s00431-021-04191-z. google scholar
17. Buescher G, Sebode M, Marjot T et al. SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience. J Pediatr Gastroenterol Nutr 2022;74: e41-e42. DOI: 10.1097/MPG.0000000000003325. google scholar
18. Cardone M, Yano M, Rosenberg AS, et al. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and harmful Hyperinflammation Front Immunol 2020; 11: 1131. 20200529. DOI: 10.3389/fimmu.2020.01131. google scholar
19. Manson JJ, Crooks C, Naja M et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol 2020; 2: e594-e602. 20200821. DOI: 10.1016/S2665-9913(20)30275-7. google scholar
20. Feldman AG, Danziger-Isakov LA. The impact of COVID-19 on the pediatric solid organ transplant population Semin Pediatr Surg 2022; 31: 151178. 20220514. DOI: 10.1016/ j.sempedsurg.2022.151178. google scholar
21. Zhong Z, Zhang Q, Xia H et al. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients Am J Transplant 2020; 20: 1916-1921. 20200504. DOI: 10.1111/ajt.15928. google scholar
22. Rodriguez-Peralvarez M, Salcedo M, Colmenero J et al. Modulating immunosuppression in liver transplant patients with COVID-19 Gut 2021; 70: 1412-1414. 20200818. DOI: 10.1136/ gutjnl-2020-322620. google scholar
23. Willicombe M, Thomas D and McAdoo S. COVID-19 and Calcineurin Inhibitors: Should They Get excluded in the Storm? J Am Soc Nephrol 2020; 31: 1145-1146. 20200420. DOI: 10.1681/ASN.2020030348. google scholar
24. Ma-Lauer Y, Zheng Y, Malesevic M et al. Influences of cyclosporin A and nonimmunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication Antiviral Res 2020; 173: 104620. 20191018. DOI: 10.1016/j.antiviral.2019.104620. google scholar
25. Wang F, Nie J, Wang H et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia J Infect Dis 2020; 221: 1762-1769. DOI: 10.1093/infdis/jiaa150. google scholar
26. Colmenero J, Rodriguez-Peralvarez M, Salcedo M et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients J Hepatol 2021; 74: 148-155. 20200801. DOI: 10.1016/j.jhep.2020.07.040. google scholar
27. Jutzeler CR, Bourguignon L, Weis CV, et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 37: 101825. 20200804. DOI: 10.1016/j.tmaid.2020.101825. google scholar
28. Liu H, Chen S, Liu M et al. Comorbid Chronic Diseases are strongly correlated with disease severity among COVID-19 patients: A systematic review and meta-analysis. Aging Dis 2020; 11: 668-678. 20200509. DOI: 10.14336/AD.2020.0502. google scholar
29. Emami A, Javanmardi F, Pirbonyeh N et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med 2020; 8: e35. 20200324. google scholar
30. Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. JAMA Pediatr 2020; 174: e202430. 20201005. DOI: 10.1001/ jamapediatrics.2020.2430. google scholar
31. Gao F, Zheng KI, Wang XB, et al. Obesity is a Risk Factor for Greater COVID-19 Severity. Diabetes Care 2020; 43: e72-e74. 20200514. DOI: 10.2337/dc20-0682. google scholar
32. Korakas E, Ikonomidis I, Kousathana F et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes Am J Physiol Endocrinol Metab 2020; 319: E105-E109. 20200527. DOI: 10.1152/ajpendo.00198.2020. google scholar
33. Melgosa M, Madrid A, Alvarez O et al. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol 2020; 35: 1521-1524. 20200520. DOI: 10.1007/ s00467-020-04597-1. google scholar